Prazosin Completed Phase N/A Trials for Alzheimer's Disease (AD) / Psychomotor Agitation Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00161473Alzheimer's in Long-Term Care--Treatment for Agitation
NCT01126099Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease